Testosterone and type 2 diabetes in men

被引：21

作者：

Mazur, Allan ^{[1
]}

Westerman, Ronny ^{[2
]}

Werdecker, Andrea ^{[2
]}

Mueller, Ulrich ^{[2
]}

机构：

[1] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA

[2] Univ Marburg, Inst Med Sociol, Marburg, Germany

来源：

AGING MALE | 2014年 / 17卷 / 01期

关键词：

Aging; fasting glucose; obesity; testosterone; Type; 2; diabetes; HORMONE-BINDING GLOBULIN; METABOLIC SYNDROME; INCREASED RISK; HEALTH; DEFICIENCY; MORTALITY;

D O I：

10.3109/13685538.2013.879113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To assess from observational data if low testosterone in men is an independent risk factor for high fasting glucose (FG) and for a diagnosis of type 2 diabetes (T2D). Methods: Multivariate analysis of data from 991 male US Air Force veterans who completed six medical examinations over 20 years. Results: Low testosterone was moderately related to high FG, independent of age and obesity. Low testosterone is a very weak predictor of a diagnosis of T2D. Conclusions: In men, low testosterone is an independent risk factor for high FG, comparable to aging and obesity. Low testosterone is a weak predictor of a diagnosis of T2D.

引用

页码：18 / 24

页数：7

共 50 条

[31] Low serum testosterone concentration in middle-aged men with type 2 diabetes
Fukui, Michiaki
Soh, Jintetsu
Tanaka, Muhei
Kitagawa, Yoshihiro
Hasegawa, Goji
Yoshikawa, Toshikazu
Miki, Tsuneharu
Nakamura, Naoto
ENDOCRINE JOURNAL, 2007, 54 (06) : 871 - 877
[32] Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes
Fukui, M
Kitagawa, Y
Nakamura, N
Kadono, M
Mogami, S
Hirata, C
Ichio, N
Wada, K
Hasegawa, G
Yoshikawa, T
DIABETES CARE, 2003, 26 (06) : 1869 - 1873
[33] Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men
Fink, Julius
Matsumoto, Masahito
Tamura, Yoshifumi
STEROIDS, 2018, 138 : 161 - 166
[34] HDL cholesterol levels are positively associated with testosterone levels in men with Type 2 diabetes
Stanworth, R. D.
Kapoor, D.
Channer, K. S.
Jones, T. H.
DIABETIC MEDICINE, 2007, 24 : 79 - 79
[35] Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease
Dhindsa, Sandeep
Reddy, Anand
Karam, Jyotheen Sukhmoy
Bilkis, Sayeeda
Chaurasia, Archana
Mehta, Aditya
Raja, Keerthi P.
Batra, Manav
Dandona, Paresh
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (03) : 359 - 366
[36] The correlation between testosterone, inflammation and cytokine status in type-2 diabetes men
Sheikh-Ahmad, Mohammad
Nakhleh, Afif
Riskin, Arieh
Yovanovich, Ekaterina
Chen-Konak, Limor
Reut, Maria
Saiegh, Leonard
ANDROLOGIA, 2022, 54 (10)
[37] Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes
Ghanim, Husam
Dhindsa, Sandeep
Batra, Manav
Green, Kelly
Abuaysheh, Sanaa
Kuhadiya, Nitesh D.
Makdissi, Antoine
Chaudhuri, Ajay
Sandhu, Sartaj
Dandona, Paresh
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : 1169 - 1175
[38] Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
Vasilkova, Olga
Mokhort, Tatiana
Sanec, Igor
Sharshakova, Tamara
Hayashida, Naomi
Takamura, Noboru
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (01) : 99 - 103
[39] Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes
Colleluori, Georgia
Aguirre, Lina
Napoli, Nicola
Qualls, Clifford
Villareal, Dennis T.
Armamento-Villareal, Reina
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (08): : E3058 - E3068
[40] The Effect of Testosterone Replacement on Glycemic Control in Hypogonadal Men with Type 2 Diabetes Mellitus
Lee, Hong S.
Bahn, Gideon
Azad, Nasrin
DIABETES, 2011, 60 : A627 - A627

← 1 2 3 4 5 →